Jonathon B. Cohen, MD, MS
Advertisement
Articles by Jonathon B. Cohen, MD, MS
Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.
Advertisement
Latest Updated Articles
Case Assessment: 68-Year-Old Patient With MCLPublished: May 18th 2020 | Updated:
Relapsed Mantle Cell Lymphoma Treatment LandscapePublished: May 18th 2020 | Updated:
Diagnosing MCL and Making Informed Treatment DecisionsPublished: May 18th 2020 | Updated:
Administration of BTK Inhibitors for Mantle Cell LymphomaPublished: May 18th 2020 | Updated:
Initiating Therapy for Mantle Cell LymphomaPublished: May 18th 2020 | Updated:
BTK Inhibitor Toxicities in Mantle Cell LymphomaPublished: May 18th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Real-World Pola-R-CHP vs R-CHOP Effectiveness in Older DLBCL Patients
5
